Recommendation: Reduce; Target Price: Rs 2250
Company’s revenue from operations witnessed a marginal increase of 3.3% at Rs9,315.14 crore.
Except pharma and auto index, all other sectoral indices were in the red with a downside ranging from 1-6%.
In Q3FY23, pending customer orders totaled approximately 3.63 lakh vehicles.
First and only FDA-approved product for treating seizures in neonatal patients.
Recommendation: Add; Target price: Rs 4225
The company will make this investment by 2030.
Company’s Net Profit declined to Rs304.17 crore in Q3FY23, down by 15.15% yoy.
Reliance Jio has become the first and the only operator to launch 5G services in most of the cities.